345 related articles for article (PubMed ID: 21855263)
1. Risk factors and outcome of Pseudomonas aeruginosa bacteremia among adults visiting the ED.
Lee CC; Lee CH; Hong MY
Am J Emerg Med; 2012 Jul; 30(6):852-60. PubMed ID: 21855263
[TBL] [Abstract][Full Text] [Related]
2. Different impact of the appropriateness of empirical antibiotics for bacteremia among younger adults and the elderly in the ED.
Lee CC; Chang CM; Hong MY; Hsu HC; Ko WC
Am J Emerg Med; 2013 Feb; 31(2):282-90. PubMed ID: 23000336
[TBL] [Abstract][Full Text] [Related]
3. Impact of inappropriate empirical antibiotic therapy on outcome of bacteremic adults visiting the ED.
Lee CC; Lee CH; Chuang MC; Hong MY; Hsu HC; Ko WC
Am J Emerg Med; 2012 Oct; 30(8):1447-56. PubMed ID: 22205015
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of Gram-negative nonfermenters on adults with community-onset bacteremia in the emergency department.
Chiu CW; Li MC; Ko WC; Li CW; Chen PL; Chang CM; Lee NY; Lee CC
J Microbiol Immunol Infect; 2015 Feb; 48(1):92-100. PubMed ID: 24060496
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for mortality of bacteremic patients in the emergency department.
Lin JN; Tsai YS; Lai CH; Chen YH; Tsai SS; Lin HL; Huang CK; Lin HH
Acad Emerg Med; 2009 Aug; 16(8):749-55. PubMed ID: 19594458
[TBL] [Abstract][Full Text] [Related]
6. Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED.
Kang CI; Chung DR; Peck KR; Song JH;
Am J Emerg Med; 2012 Sep; 30(7):1169-75. PubMed ID: 22030178
[TBL] [Abstract][Full Text] [Related]
7. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Wang SS; Lee NY; Hsueh PR; Huang WH; Tsui KC; Lee HC; Wu CJ; Chang CM; Huang CC; Huang CF; Ko WC
J Microbiol Immunol Infect; 2011 Aug; 44(4):282-8. PubMed ID: 21524962
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and impact of empirical therapy in cirrhotic adults with community-onset bacteremia.
Hsieh CC; Lee CC; Chan TY; Hong MY; Chi CH; Ko WC
Am J Emerg Med; 2015 Feb; 33(2):222-8. PubMed ID: 25498529
[TBL] [Abstract][Full Text] [Related]
10. Different clinical presentation of community-onset bacteremia among human immunodeficiency virus-infected and human immunodeficiency virus-uninfected adults in the ED.
Lee CC; Chu FY; Ko WC; Chi CH
Am J Emerg Med; 2014 Oct; 32(10):1241-7. PubMed ID: 25171801
[TBL] [Abstract][Full Text] [Related]
11. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.
Lodise TP; Patel N; Kwa A; Graves J; Furuno JP; Graffunder E; Lomaestro B; McGregor JC
Antimicrob Agents Chemother; 2007 Oct; 51(10):3510-5. PubMed ID: 17646415
[TBL] [Abstract][Full Text] [Related]
12. Prediction of community-onset bacteremia among febrile adults visiting an emergency department: rigor matters.
Lee CC; Wu CJ; Chi CH; Lee NY; Chen PL; Lee HC; Chang CM; Ko NY; Ko WC
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):168-73. PubMed ID: 22463870
[TBL] [Abstract][Full Text] [Related]
13. Pitfalls in using serum C-reactive protein to predict bacteremia in febrile adults in the ED.
Lee CC; Hong MY; Lee NY; Chen PL; Chang CM; Ko WC
Am J Emerg Med; 2012 May; 30(4):562-9. PubMed ID: 21514766
[TBL] [Abstract][Full Text] [Related]
14. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
López-Dupla M; Martínez JA; Vidal F; Almela M; Soriano A; Marco F; López J; Olona M; Mensa J
Am J Infect Control; 2009 Nov; 37(9):753-8. PubMed ID: 19487049
[TBL] [Abstract][Full Text] [Related]
15. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.
Kang CI; Kim SH; Kim HB; Park SW; Choe YJ; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):745-51. PubMed ID: 12955633
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy.
Schechner V; Gottesman T; Schwartz O; Korem M; Maor Y; Rahav G; Karplus R; Lazarovitch T; Braun E; Finkelstein R; Lachish T; Wiener-Well Y; Alon D; Chowers M; Bardenstein R; Zimhony O; Paz A; Potasman I; Giladi M; Schwaber MJ; Klarfeld-Lidji S; Hochman M; Marchaim D; Carmeli Y
Diagn Microbiol Infect Dis; 2011 Sep; 71(1):38-45. PubMed ID: 21763093
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy.
Tuon FF; Gortz LW; Rocha JL
Braz J Infect Dis; 2012; 16(4):351-6. PubMed ID: 22846123
[TBL] [Abstract][Full Text] [Related]
19. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE
J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354
[TBL] [Abstract][Full Text] [Related]
20. Isolated pathogens and clinical outcomes of adult bacteremia in the emergency department: a retrospective study in a tertiary Referral Center.
Kao CH; Kuo YC; Chen CC; Chang YT; Chen YS; Wann SR; Liu YC
J Microbiol Immunol Infect; 2011 Jun; 44(3):215-21. PubMed ID: 21524617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
